Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| TRANS1 INC | 141,128 | reported | 15 Aug 2014 | tx 16+1,035,046 |
| Bioventus Inc. | 30,085 | reported | 15 Mar 2023 | tx 8+650,832−38,532 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 15 Mar 2023 | SALE | Bioventus Inc. | 9,811 | 1.39 USD | |
| 14 Mar 2023 | EXERCISE | Bioventus Inc. | 28,721 | — | |
| 14 Mar 2023 | EXERCISE | Bioventus Inc. | 28,721 | 0.00 USD | deriv |
| 14 Mar 2022 | GRANT_AWARD | Bioventus Inc. | 114,882 | 0.00 USD | deriv |
| 09 Sept 2021 | PURCHASE | Bioventus Inc. | 1,800 | 14.81 USD | |
| 11 Feb 2021 | PURCHASE | Bioventus Inc. | 9,375 | 13.00 USD | first after silence |
| 01 Apr 2021 | GRANT_AWARD | Bioventus Inc. | 30,000 | 0.00 USD | deriv |
| 15 Aug 2014 | PURCHASE | TRANS1 INC | 10,000 | 0.38 USD | |
| 12 May 2014 | PURCHASE | TRANS1 INC | 5,719 | 0.71 USD | |
| 12 May 2014 | PURCHASE | TRANS1 INC | 1,331 | 0.72 USD | |
| 02 Jan 2014 | GRANT_AWARD | TRANS1 INC | 100,000 | 0.00 USD | |
| 05 Dec 2013 | PURCHASE | TRANS1 INC | 10,500 | 1.11 USD | first after silence |
| 31 May 2013 | GRANT_AWARD | TRANS1 INC | 6,578 | 2.28 USD | |
| 01 Mar 2013 | GRANT_AWARD | TRANS1 INC | 243,918 | 0.00 USD | deriv |
| 07 Jun 2012 | PURCHASE | TRANS1 INC | 1,160 | 2.55 USD | |
| 07 Jun 2012 | PURCHASE | TRANS1 INC | 3,500 | 2.56 USD | |
| 07 Jun 2012 | PURCHASE | TRANS1 INC | 2,000 | 2.60 USD | |
| 07 Jun 2012 | PURCHASE | TRANS1 INC | 340 | 2.63 USD | |
| 25 Jan 2012 | GRANT_AWARD | TRANS1 INC | 200,000 | 0.00 USD | deriv |
| 22 Feb 2011 | GRANT_AWARD | TRANS1 INC | 50,000 | 0.00 USD | deriv |
| 22 Feb 2011 | GRANT_AWARD | TRANS1 INC | 50,000 | 0.00 USD | deriv |
| 22 Feb 2011 | GRANT_AWARD | TRANS1 INC | 50,000 | 0.00 USD | deriv |
| 12 Jan 2010 | GRANT_AWARD | TRANS1 INC | 300,000 | 0.00 USD | deriv |
2 purchases reported after at least 12 months of silence — most recent on 11 Feb 2021.